EMT phenotype

Aliases

EMT phenotype, epithelial-mesenchymal transition

No related entities found.

Mentioned in (17)

Papers in which this entity is mentioned.

• DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis. (2025)
• Chromosomal instability as a driver of cancer progression. (2025)
• Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning. (2024)
• ENPP1 Immunobiology as a Therapeutic Target. (2023)
• ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. (2022)
• Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. (2022)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• Hydra: A mixture modeling framework for subtyping pediatric cancer cohorts using multimodal gene expression signatures. (2020)
• Maternal circulating miRNAs that predict infant FASD outcomes influence placental maturation. (2019)
• Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
• Plasma miRNA Profiles in Pregnant Women Predict Infant Outcomes following Prenatal Alcohol Exposure. (2016)
• Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges. (2013)
• Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
• Functional consequences of developmentally regulated alternative splicing. (2011)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.